Key result
The modified HEART score identified 36% of pre-hospital chest pain patients without ST-segment elevation as low risk, with 0% experiencing a major adverse cardiac event at 30 days.
Why the study?
Does pre-hospital triage using the modified HEART score safely rule out myocardial infarction in chest pain patients without ST-elevation?
Cohort (n=1,127)
Does pre-hospital triage using the modified HEART score safely rule out myocardial infarction in chest pain patients without ST-elevation?
The modified HEART score, utilizing a single pre-hospital high-sensitivity troponin T measurement, can safely identify low-risk chest pain patients who do not require hospital transfer.
Answers are grounded in this paper and cite their sources.
May support pre-hospital low-risk identification; hypothesis-generating pending prospective validation before practice change.
BACKGROUND: The first study of the FamouS Triage project investigates the feasibility of ruling out a myocardial infarction in pre-hospital chest pain patients without electrocardiographic ST-segment elevation by using the modified HEART score at the patient's home, incorporating only a single highly sensitive troponin T measurement. METHODS: A venous blood sample was drawn in the ambulance from 1127 consecutive chest pain patients for measurement of the pre-hospital highly sensitive troponin T levels, in order to establish a pre-hospital HEART score (i.e. the modified HEART score) and evaluate the possibility of triage at the patient's home. The primary endpoint was the occurrence of a major adverse cardiac event (MACE) i.e. acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting or death within 30 days after initial presentation. RESULTS: Two hundred and six patients (18%) developed a MACE during 30 days of follow-up. Thirty-six per cent of the patients ( n=403) had a low modified HEART score (0-3 points) and none of them developed a MACE during follow-up. Forty-four per cent of the patients ( n=494) had an intermediate modified HEART score (4-6 points) and 18% of them developed a MACE. Twenty per cent of the patients ( n=230) had a high modified HEART score (7-10 points) of which 52% developed a MACE during follow-up. CONCLUSION: It seems feasible to rule out a myocardial infarction at home in chest pain patients without ST-segment elevation by using the modified HEART score. TRIAL ID: NTR4205. Dutch Trial Register [ http://www.trialregister.nl ]: trial number 4205.
No takes yet. Share an insight, caveat, or question.
Ishak et al. (2017) conducted a cohort in Pre-hospital chest pain without ST-segment elevation (n=1,127). Modified HEART score was evaluated on Major adverse cardiac event (MACE) i.e. acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting or death within 30 days. The modified HEART score identified 36% of pre-hospital chest pain patients without ST-segment elevation as low risk, with 0% experiencing a major adverse cardiac event at 30 days.
Synapse has enriched 10 related papers. Consider them for comparative context: